Elicio Therapeutics price target raised to $17 from $13 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Elicio Therapeutics (ELTX) to $17 from $13 and keeps a Buy rating on the shares. To reflect the data seen to date, the firm increased its probability of success for ELI-002 to 50% from 30%.